Doesn't the technique in that paper seem like just a fancy way to elevate
the temperature briefly? What else could zapping with a 780 nm laser do?
Also, it seems that since N = 1, the technique is way too nascent (and it
might be stillborn) to be applied.
Jacob Keller
*******************************************
Jacob Pearson Keller
Northwestern University
Medical Scientist Training Program
Dallos Laboratory
F. Searle 1-240
2240 Campus Drive
Evanston IL 60208
lab: 847.491.2438
cel: 773.608.9185
email: [EMAIL PROTECTED]
*******************************************
----- Original Message -----
From: "Ian Tickle" <[EMAIL PROTECTED]>
To: <[email protected]>
Sent: Thursday, July 24, 2008 4:52 AM
Subject: Re: [ccp4bb] microfluidics in protein crystallography
Also while we're on the subject of novel crystallisation tricks, does anyone
out there have any first-hand impressions of this technique:
http://jjap.ipap.jp/link?JJAP/44/1365/
Cheers
-- Ian
-----Original Message-----
From: [EMAIL PROTECTED]
[mailto:[EMAIL PROTECTED] On Behalf Of Isabel Garcia-Saez
Sent: 22 July 2008 10:34
To: [email protected]
Subject: microfluidics in protein crystallography
Dear CCP4ers,
I would like to have more info about microfluidics in protein
xtallography: has anyone out there used it with success?.
Thanks,
Isabel
Isabel Garcia-Saez PhD
Institut de Biologie Structurale Jean-Pierre Ebel
Laboratoire des Protéines du Cytosquelette
41, rue Jules Horowitz
F-38027 Grenoble CEDEX 1
France
tel.: 00-33-438 789615
FAX: 00-33-438 785494
e-mail: [EMAIL PROTECTED]
http://www.ibs.fr
Disclaimer
This communication is confidential and may contain privileged information
intended solely for the named addressee(s). It may not be used or disclosed
except for the purpose for which it has been sent. If you are not the
intended recipient you must not review, use, disclose, copy, distribute or
take any action in reliance upon it. If you have received this communication
in error, please notify Astex Therapeutics Ltd by emailing
[EMAIL PROTECTED] and destroy all copies of the message and
any attached documents.
Astex Therapeutics Ltd monitors, controls and protects all its messaging
traffic in compliance with its corporate email policy. The Company accepts
no liability or responsibility for any onward transmission or use of emails
and attachments having left the Astex Therapeutics domain. Unless expressly
stated, opinions in this message are those of the individual sender and not
of Astex Therapeutics Ltd. The recipient should check this email and any
attachments for the presence of computer viruses. Astex Therapeutics Ltd
accepts no liability for damage caused by any virus transmitted by this
email. E-mail is susceptible to data corruption, interception, unauthorized
amendment, and tampering, Astex Therapeutics Ltd only send and receive
e-mails on the basis that the Company is not liable for any such alteration
or any consequences thereof.
Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science
Park, Cambridge CB4 0QA under number 3751674
